IIR Know how to achieve
Home About IIR FAQ Partnerships Sponsorship IIR Careers Contact Us
 
Knowledge and Skills Channels
Conference | Exhibition | Training | Documentation

  Event Registration  
Click Here to register

 
   
Event Menu
  Law and Compliance Homepage
  Event Home
  Venue
  Call for Paper
  Register
  Contact Us
Go to your Industry Sector
 

IIR Law and Compliance

Biotech and Pharmaceutical Patenting

  
   

Biotech and Pharmaceutical Patenting
Register online or Call:
Customer Services
Tel: +44 (0) 20 7017 5503
Email:  professionalcustserv@info orma.com
registration registration
download event brochure download event brochure
sign-up for e-Updates sign-up for e-Updates
 
Mon 26 Jan 2009 - Tue 27 Jan 2009
Le Meridien Munich, Munich, Germany

This in-depth and specialised conference will focus on the more difficult aspects of patents, offering a variety of views from patent practitioners, an EPO representative and a member of the European Commission. Of particular interest to Patent Attorneys, Patent Counsel, as well as IP Lawyers from a wide geographical and industrial background, this conference will explain how to deal with the unusual loops and nuances that can arise.

Craft your patent claims and specifications with this effective interpretation of the requirements and restrictions:

> Access the latest thinking on the law of obviousness, litigation strategies in the light of the sector enquiry, opposition system reform, Bolar implementation, as well as medical use claims and dosage requirements.

> Deal with the unusual loops and nuances that can arise with practical examples of the difficult patent protection and litigation processes

> Build on your experience with specialised and relevant guidance from experienced industry speakers

Our expert panel of speakers include:

v Dr Christopher Heath, Member, Board of Appeal, EPO

v Lorena Boix Alonso, Deputy Head of Cabinet, Cabinet of Mrs Neelie Kroes, Commissioner for Competition, European Commission

v Allen Norris, Vice President, Head of Group IP, UCB Pharma SA

v Howard Rosenberg, formerly Group IP and API Strategy Director, Merck Generics

v Giampiero De Luca, Senior Executive Vice President, Licensing and Intellectual Property, Merck Serono

v Dr Frank Burkert, European Patent Attorney, Bayer Healthcare AG

v Bo Hammer Jensen, Director and Senior Patent Counsel, Novozymes AS

v Birgitte Stephensen, Vice President, IPR & Legal, Genmab A/S

v Dr Rudolf Teschemacher, Consultant, Bardehle Pagenberg Dost Altenburg Geissler; former Member, Boards of Appeal and Enlarged Board of Appeal, European Patent Office

v Chris Mercer, Partner, Carpmaels and Ransford; former President of EPI

v Kevin Mooney, Partner, Simmons & Simmons

v Gordon Wright, Partner, Elkington & Fife

v Ian Karet, Partner, Linklaters

v Reinhardt Schuster, Partner, Bardehle Pagenberg Dost Altenburg Geissler

v Morag Macdonald, Partner/Joint Head of International IP Group, Bird and Bird

v Mario Siragusa, Partner, Cleary Gottlieb Steen & Hamilton LLP

v Rowan Freeland, Partner, Simmons & Simmons

v Simon Cohen, Partner, Taylor Wessing

v Dr. Thomas W. Reimann, Attorney, Reimann Osterrieth Köhler Haft

v Bruce C. Haas, Partner, Fitzpatrick, Cella, Harper & Scinto

v Paul Inman, Partner, Howrey

v Dr. Jürgen Meier, Partner, Vossius & Partner

v Ian Dodds-Smith, Partner, Arnold & Porter

v Dr Ederyn Williams, Director, Warwick Ventures

v Bert Oosting, Partner, Lovells

v Sarah Turner, Of Counsel, Lovells

As the must attend event, the Biotech and Pharmaceutical Patenting conference will digest and debate the leading cases, and summarise the European and US law progress.

 



Don't Miss

The cocktail reception sponsored by Lovells!

Key Presentations

The two day conference will mainly comprise plenary and panel sessions to encourage feedback and interaction with the audience. Attend this event to:

  • Examine competition law and the sectoral investigation in the pharmaceutical industry
  • Debate on patent enforcement - litigation strategies in the light of the sector enquiry
  • Analyse the law of obviousness and where is it going?
  • Discuss whether there is a need to reform the opposition system
  • Assess Bolar implementation
  • Discuss Medical Use Claims and dosage requirements
  • Examine diagnostic methods
  • Analyse stem cells
  • Receive a regulatory update
  • Explore the key issues of the Freedom to Operate

Discuss the experience of universities versus the experience of industry on exploiting and negotiating – and the lessons learned on both sides



Register Now!
Register online or call:
Customer Services
Tel: +44 (0) 20 7017 5503
Email:professionalcustserv@informa.com
Group Discounts
For more info call:
Customer Services
Tel: +44 (0) 20 7017 5503
Email:professionalcustserv@informa.com
Speaker Opportunities
To discuss opportunities call:
Catherine Watson
Tel: +44 (0)20 7017 5005
Email:catherine.watson@informa.com
Sponsorship and Exhibition
To discuss opportunities call:
Ravi Patel
Tel: +44 (20) 701 74940
Email:rpatel@iirltd.co.uk